Cosmo Pharmaceuticals N.V. logo

Cosmo Pharmaceuticals N.V.

SIX:COPN.SW

Overview | Financials
Company Name Cosmo Pharmaceuticals N.V.
Symbol COPN.SW
Currency CHF
Price 66.8
Market Cap 1,071,863,715
Dividend Yield 1.41%
52-week-range 36 - 80.6
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Alessandro E. Della Cha LL.M
Website https://www.cosmopharma.com

An error occurred while fetching data.

About Cosmo Pharmaceuticals N.V.

Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and

Related Stocks

Medartis Holding AG logo

Medartis Holding AG

MED.SW

55.5 CHF

COLTENE Holding AG logo

COLTENE Holding AG

CLTN.SW

56.4 CHF

Basilea Pharmaceutica AG logo

Basilea Pharmaceutica AG

BSLN.SW

43.65 CHF

Ascom Holding AG logo

Ascom Holding AG

ASCN.SW

4.63 CHF

IVF Hartmann Holding AG logo

IVF Hartmann Holding AG

VBSN.SW

143 CHF

SHL Telemedicine Ltd. logo

SHL Telemedicine Ltd.

SHLTN.SW

8.9 CHF

Relief Therapeutics Holding AG logo

Relief Therapeutics Holding AG

RLF.SW

6.1 CHF

Molecular Partners AG logo

Molecular Partners AG

MOLN.SW

5.06 CHF

Aevis Victoria SA logo

Aevis Victoria SA

AEVS.SW

13.9 CHF

Financials

Numbers are in millions USD

Numbers are in millions USD